{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:15:07Z","timestamp":1781972107449,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,16]]},"DOI":"10.7759\/cureus.50632","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T21:06:10Z","timestamp":1702760770000},"source":"Crossref","is-referenced-by-count":2,"title":["Ceftriaxone Resistance in Campylobacter Gastroenteritis"],"prefix":"10.7759","author":[{"given":"Megan D","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Phuc D","family":"Ta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satori","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. Campylobacter (Campylobacteriosis). (2021). Accessed. December 12, 2023: https:\/\/www.cdc.gov\/campylobacter\/index.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/509936","article-title":"The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken","volume":"44","author":"Ruiz-Palacios GM","year":"2007","unstructured":"Ruiz-Palacios GM. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. Clin Infect Dis. 2007, 44:701-3. 10.1086\/509936","journal-title":"Clin Infect Dis"},{"key":"ref3","unstructured":"Causes and symptoms of campylobacteriosis. MN Dept. of Health. (2023). Accessed. December 12, 2023: https:\/\/www.health.state.mn.us\/diseases\/campylobacteriosis\/basics.html."},{"key":"ref4","unstructured":"Levaquin, levofloxacin systemic (levofloxacin) dosing, indications, interactions, adverse effects, and more. (2023). Accessed. December 12, 2023: https:\/\/reference.medscape.com\/drug\/levaquin-levofloxacin-systemic-levofloxacin-342532."},{"key":"ref5","unstructured":"CIPRO\u00ae (ciprofloxacin hydrochloride) tablets. (2013). Accessed. December 12, 2023: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2005\/019537s057,020780s019lbl.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a816","article-title":"FDA adds \"black box\" warning label to fluoroquinolone antibiotics","volume":"337","author":"Tanne JH","year":"2008","unstructured":"Tanne JH. FDA adds \"black box\" warning label to fluoroquinolone antibiotics. BMJ. 2008, 337:a816. 10.1136\/bmj.a816","journal-title":"BMJ"},{"key":"ref7","unstructured":"Are antibiotics causing tendon ruptures in sports?. (2020). Accessed. December 12, 2023: https:\/\/simplifaster.com\/articles\/antibiotics-tendon-ruptures-athletes\/."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1988.tb04058.x","article-title":"Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions","volume":"8","author":"LeBel M","year":"1988","unstructured":"LeBel M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy. 1988, 8:3-33. 10.1002\/j.1875-9114.1988.tb04058.x","journal-title":"Pharmacotherapy"},{"key":"ref9","unstructured":"Ceftriaxone injection uses, side effects & warnings. (2023). Accessed. December 12, 2023: https:\/\/www.drugs.com\/mtm\/ceftriaxone-injection.html."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62744-y","article-title":"Campylobacter gastroenteritis in children in north-eastern Israel comparison with other common pathogens","volume":"10","author":"Sakran W","year":"2020","unstructured":"Sakran W, Hexner-Erlichman Z, Spiegel R, Batheesh H, Halevy R, Koren A. Campylobacter gastroenteritis in children in north-eastern Israel comparison with other common pathogens. Sci Rep. 2020, 10:5823. 10.1038\/s41598-020-62744-y","journal-title":"Sci Rep"},{"key":"ref11","unstructured":"Ceftriaxone. Uses, interactions, mechanism of action. (2023). Accessed: December 12, 2023: https:\/\/go.drugbank.com\/drugs\/DB01212."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-016-0197-x","article-title":"Ceftriaxone-associated biliary and cardiopulmonary adverse events in neonates: a systematic review of the literature","volume":"19","author":"Donnelly PC","year":"2017","unstructured":"Donnelly PC, Sutich RM, Easton R, Adejumo OA, Lee TA, Logan LK. Ceftriaxone-associated biliary and cardiopulmonary adverse events in neonates: a systematic review of the literature. Paediatr Drugs. 2017, 19:21-34. 10.1007\/s40272-016-0197-x","journal-title":"Paediatr Drugs"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3080","article-title":"Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events","volume":"123","author":"Bradley JS","year":"2009","unstructured":"Bradley JS, Wassel RT, Lee L, Nambiar S. Intravenous ceftriaxone and calcium in the neonate: assessing the risk for cardiopulmonary adverse events. Pediatrics. 2009, 123:e609-13. 10.1542\/peds.2008-3080","journal-title":"Pediatrics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1556\/EuJMI.2.2012.1.11","article-title":"Campylobacter bacteremia: a rare and under-reported event?","volume":"2","author":"Louwen R","year":"2012","unstructured":"Louwen R, van Baarlen P, van Vliet AH, van Belkum A, Hays JP, Endtz HP. Campylobacter bacteremia: a rare and under-reported event?. Eur J Microbiol Immunol (Bp). 2012, 2:76-87. 10.1556\/EuJMI.2.2012.1.11","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"ref15","article-title":"Campylobacter jejuni meningitis [Article in French]","volume":"74","author":"Skripkina E","year":"2019","unstructured":"Skripkina E, Canivet A, Wautier M, Martiny D, Hallin M, Meex C, Layios N. Campylobacter jejuni meningitis [Article in French]. Rev Med Liege. 2019, 74:420-3.","journal-title":"Rev Med Liege"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4161\/viru.2.1.14752","article-title":"Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials","volume":"2","author":"Keo T","year":"2011","unstructured":"Keo T, Collins J, Kunwar P, Blaser MJ, Iovine NM. Campylobacter capsule and lipooligosaccharide confer resistance to serum and cationic antimicrobials. Virulence. 2011, 2:30-40. 10.4161\/viru.2.1.14752","journal-title":"Virulence"},{"key":"ref17","unstructured":"Ciprofloxacin tablets (CIPRO). (2023). Accessed. December 12, 2023: https:\/\/my.clevelandclinic.org\/health\/drugs\/18639-ciprofloxacin-tablets."},{"key":"ref18","article-title":"Campylobacter: from microbiology to prevention","volume":"58","author":"Facciol\u00e0 A","year":"2017","unstructured":"Facciol\u00e0 A, Riso R, Avventuroso E, Visalli G, Delia SA, Lagan\u00e0 P. Campylobacter: from microbiology to prevention. J Prev Med Hyg. 2017, 58:E79-92.","journal-title":"J Prev Med Hyg"},{"key":"ref19","unstructured":"Annual report of animal contact outbreaks. (1991). Accessed. December 12, 2023: https:\/\/www.cdc.gov\/acoss\/annual-reports\/index.html#:~:text=In%202017%2C%2059%20outbreaks%20of,158%20illnesses%2C%20a...."},{"key":"ref20","unstructured":"Roe crops. how Sacramento became the caviar capital of the U.S. (2023). Accessed: December 12, 2023: https:\/\/caseagrant.ucsd.edu\/news\/roe-crops-how-sacramento-became-caviar-capital-us#:~:text=It%20turns%20out%20the%20g...."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-15","article-title":"Global epidemiology of Campylobacter infection","volume":"28","author":"Kaakoush NO","year":"2015","unstructured":"Kaakoush NO, Casta\u00f1o-Rodr\u00edguez N, Mitchell HM, Man SM. Global epidemiology of Campylobacter infection. Clin Microbiol Rev. 2015, 28:687-720. 10.1128\/CMR.00006-15","journal-title":"Clin Microbiol Rev"},{"key":"ref22","unstructured":"World Health Organization. Meningitis. (2023). Accessed. December 12, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/meningitis."},{"key":"ref23","unstructured":"Initial therapy and prognosis of community-acquired bacterial meningitis in adults. (2023). Accessed. December 12, 2023: https:\/\/www.uptodate.com\/contents\/initial-therapy-and-prognosis-of-community-acquired-bacterial-meningitis-in-adults."},{"key":"ref24","doi-asserted-by":"crossref","DOI":"10.4172\/2167-7182.1000426","article-title":"Colitis due to Campylobacter jejuni\/coli: ceftriaxone is not effective","author":"Emonet S","year":"2017","unstructured":"Emonet S, Redzepi B, Riat, et al.. Colitis due to Campylobacter jejuni\/coli: ceftriaxone is not effective. Journal of Gerontology & Geriatric Research. 2017,","journal-title":"Journal of Gerontology & Geriatric Research"},{"key":"ref25","unstructured":"CDC. Campylobacter (Campylobacteriosis). (2022). Accessed. December 12, 2023: https:\/\/www.cdc.gov\/campylobacter\/campy-antibiotic-resistance.html."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/208903-ceftriaxone-resistance-in-campylobacter-gastroenteritis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:35Z","timestamp":1707509435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/208903-ceftriaxone-resistance-in-campylobacter-gastroenteritis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.50632","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,16]]}}}